KARAKILIÇ ÖZTURAN, E. Et Al. 2021. Response to growth hormone therapy with high IGF-1-levels and severe insulin resistance in two-cases with SOFT syndrome: A novel homozygous mutation in POC1A. 59th Annual ESPE (ESPE 2021 Online) , 277.

KARAKILIÇ ÖZTURAN, E., ALTUNOĞLU, U., ÖZTÜRK, A. P., TOKSOY, G., TUTKU TURGUT, G., POYRAZOĞLU, Ş., ... BAŞ, F.(2021). Response to growth hormone therapy with high IGF-1-levels and severe insulin resistance in two-cases with SOFT syndrome: A novel homozygous mutation in POC1A . 59th Annual ESPE (ESPE 2021 Online) (pp.277).

KARAKILIÇ ÖZTURAN, Esin Et Al. "Response to growth hormone therapy with high IGF-1-levels and severe insulin resistance in two-cases with SOFT syndrome: A novel homozygous mutation in POC1A," 59th Annual ESPE (ESPE 2021 Online), 2021

KARAKILIÇ ÖZTURAN, Esin K. Et Al. "Response to growth hormone therapy with high IGF-1-levels and severe insulin resistance in two-cases with SOFT syndrome: A novel homozygous mutation in POC1A." 59th Annual ESPE (ESPE 2021 Online) , pp.277, 2021

KARAKILIÇ ÖZTURAN, E. Et Al. (2021) . "Response to growth hormone therapy with high IGF-1-levels and severe insulin resistance in two-cases with SOFT syndrome: A novel homozygous mutation in POC1A." 59th Annual ESPE (ESPE 2021 Online) , p.277.

@conferencepaper{conferencepaper, author={Esin KARAKILIÇ ÖZTURAN Et Al. }, title={Response to growth hormone therapy with high IGF-1-levels and severe insulin resistance in two-cases with SOFT syndrome: A novel homozygous mutation in POC1A}, congress name={59th Annual ESPE (ESPE 2021 Online)}, city={}, country={}, year={2021}, pages={277} }